Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update

Systemic therapy for hepatocellular carcinoma (HCC) has changed markedly since the introduction of the molecular targeted agent sorafenib in 2007. Sorafenib increased the available treatment options for patients with extrahepatic spread and vascular invasion and improved survival in patients with ad...

Full description

Bibliographic Details
Main Author: Masatoshi Kudo
Format: Article
Language:English
Published: Karger Publishers 2020-11-01
Series:Liver Cancer
Subjects:
Online Access:https://www.karger.com/Article/FullText/511001